COVID-19

 

HBI updates dental market forecasts as operators face second wave

Dental markets have reopened following the pandemic peak but the impact may be felt for many months to come, not least because of a second wave winter. HBI has added new post-COVID market size data on the Intelligence platform based on conversations with operators. Most think new national lockdowns are unlikely but regional lockdowns, prolonged economic uncertainty for patients, and scared patients are all causing concern.

Concerns COVID is turning dentistry into a reactive service

Delays in treatment caused directly by COVID-19 and a reluctance to attend routine appointments are turning preventative dental markets into reactive ones. The financial pressures resulting from the pandemic means there might not be a big enough supply of dentists to cope with the pent up demand.

European operators brace for second wave

COVID's second wave looks either imminent, or is already starting to hit in many jurisdictions. Wave one saw lockdowns and closures - and not all closures were temporary. Will wave two be any different? HBI has been talking to operators across EMEA to see if forewarned is forearmed, how they predict the next few months will go, and what lessons have been learned.

Diversification helps Grupo 5 grow despite COVID

Grupo 5 has carved out an unusual but successful niche for itself in Spain, balancing a mix of healthcare services (predominantly mental health and treatment for patients with brain injuries) with social emergency care for the homeless, children, and people with disability. CEO Guillermo Bell tells HBI it has proved to be a robust combination during the COVID crisis.

How Covid opens up new B2B and B2C testing markets

The lab sector could be "uberised" by an app which currently enables individuals to see where, and when they can get a Covid test as part of government and corporate schemes. The aim is to create a consumer solution which will enable individuals to select from a very wide range of tests on price and proximity.

Employee testing drives 30%+ organic growth for labs through summer

COVID-19 testing for businesses, the sports industry and governments has cancelled-out and countered most falls in routine testing for the pan-European lab groups. Synlab says it signed 3,000 back-to-work testing contracts and saw 32% y-o-y organic revenue growth in June while Eurofins has 1,200 signed or in discussion. HBI examines the impact of the pandemic so far and what's next.

Apollo Q1 results highlight scope of COVID impact in India

The effect of the COVID crisis was evident in Indian hospital chain Apollo's Q1 results, announced on Monday. It reported a consolidated net loss of Rs 226 crore ($31m) for the quarter ending June 30, but there was a silver lining in the growth of it's pharmacy business.

UK care homes show resilience, but in urgent need of preventative and crisis funding

According to a new report the UK care home sector is showing some resilience despite COVID-19, with occupancy steadily improving as confidence improves in the sector and care homes better prepared for an imminent risk of resurgence. Despite this, thousands remain at risk of closure and in need of stronger government support.

NHS England trims operator list as PMI drives private pay recovery

We reveal which UK private hospital operators are still in NHS England's new national agreement and which left it on Tuesday, September 8. Private medical insurers (PMI) are 'busting' to get policyholders treated after delays but operators face a delicate balancing act in also helping the NHS clear waiting lists, an analyst tells HBI, as the market recovers to 70-80% of 2019 activity levels during July and August. 

Ada Health building diagnostic results into its app

In the peak of Germany's pandemic, symptom-checker app Ada Health rapidly built a solution to digitally return COVID-19 test results to a lab's customers. Founder Claire Novorol tells HBI that the new capability is part of a long term strategy that will allow the company to better incorporate diagnostic data into its app.

Find Us